Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-945-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Principles of method if other than guideline:
- The aim of this study was to assess the toxicity potential of Reaction mass of Cardanol diene and Cardanol monoene and Cardanol triene (CAS No. – 37330-39-5) after single oral administration in Rats and an observation period of 14 days
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Reaction mass of Cardanol diene and Cardanol monoene and Cardanol triene
- Cas Number:
- 37330-39-5
- Molecular formula:
- C(21)H(31-36)O
- IUPAC Name:
- Reaction mass of Cardanol diene and Cardanol monoene and Cardanol triene
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Species:Rattus norvegicus (Rat)Strain:Wistar Number and Sex:Twelve FemalesSupplier / Source: In-house animals, bred at Animal House.Health Status:Healthy young adult animals were used for the study. Females were nulliparous and non pregnant.Body weight of animals:Minimum: 136 g Maximum: 160 g (Individual body weights were within ± 20 % prior to treatment after overnight fasting)Age: 8 - 12 weeks at the time of dosing.Acclimatisation:Animal nos. 1-3 was acclimatized for 6 days, 4-6 for 10 days, 7-9 for 13 days and 10-12 for 6 days prior to administration of the test item. Identification:The animals were marked temporarily on tail, permanently on toe pad micro tattooing and cage cards. Individual cage cards were labelled with study no., study type, test system, group, dose, sex, animal number, experimental start and completion date.Husbandry ConditionsDiet:All animals were provided conventional laboratory rodent dietBedding:All cages were provided with corn cobs Water: Aqua guard filtered tap water was provided ad libitum via drinking bottles.Husbandry:Group of three animals were housed in polycarbonate cages.Room Sanitation:The experimental room floor and work tops were swept and mopped with disinfectant solution every day. Cages and water bottle:All the cages and water bottles were changed at least twice every week.Experimental Room ConditionTemperature:Minimum: 20.40 °C Maximum: 22.40 °CRelative humidity:Minimum: 49.10% Maximum: 67.30%Light-dark-rhythm: 12 hour light and 12 hour darkAir Changes: More than 12 changes per hour
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLECorn oil was selected as a vehicle based on solubility testing.
- Doses:
- 300 mg/kg bw and 2000 mg/kg bw
- No. of animals per sex per dose:
- 300 mg/kg bw -6 female rats2000 mg/kg bw-6 female rats
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days - Frequency of observations and weighing: daily- Necropsy of survivors performed: yes- Other examinations performed: clinical signs, mortality, body weight, pathology
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Non toxic
- Mortality:
- No mortality was observed in animals treated with 300 and 2000 mg/kg body weight throughout the 14 days observation period.
- Clinical signs:
- At 300 and 2000 mg/kg body weight, all the animals were observed normal throughout the experimental period.
- Body weight:
- Mean body weight of all the animals treated with 300 and 2000 mg/kg body weight were observed with gain on day 7 and 14, as compared to day 0
- Gross pathology:
- During external and internal gross pathological examination, terminally sacrificed animals treated with 300 and 2000 mg/kg body weight were observed with no abnormalities.
Any other information on results incl. tables
Table 1: Individual Animal Body Weight (g) andBody Weight Changes(%)
Sex:Female
Animal No. | Group/ Dose (mg/kg body weight) |
| Body Weight (gram) | Body Weight Change (%) | |||
Dose Volume* | Day 0 | Day 7 | Day 14 | Day 0-7 | Day 0-14 | ||
1 | G1/ 300 | 1.5 | 149 | 182 | 197 | 22.15 | 32.21 |
2 | 1.4 | 136 | 174 | 190 | 27.94 | 39.71 | |
3 | 1.6 | 158 | 194 | 206 | 22.78 | 30.38 | |
4 | 1.4 | 142 | 182 | 201 | 28.17 | 41.55 | |
5 | 1.4 | 142 | 180 | 191 | 26.76 | 34.51 | |
6 | 1.5 | 152 | 191 | 197 | 25.66 | 29.61 | |
7 | G2/ 2000 | 1.5 | 152 | 189 | 191 | 24.34 | 25.66 |
8 | 1.4 | 142 | 168 | 180 | 18.31 | 26.76 | |
9 | 1.6 | 156 | 186 | 200 | 19.23 | 28.21 | |
10 | 1.5 | 154 | 226 | 238 | 46.75 | 54.55 | |
11 | 1.6 | 155 | 218 | 229 | 40.65 | 47.74 | |
12 | 1.6 | 160 | 233 | 242 | 45.63 | 51.25 |
*= Dose volume calculated based on day 0 body weight
Table 2: Summary of Animal Body Weight (g) and Body Weight Changes (%)
Sex:Female
Group/ Dose (mg/kg body weight) | Rats Body Weight (g) | Body Weight Changes (%) | ||||
Day 0 | Day 7 | Day 14 | 0-7 | 0-14 | ||
G1/ 300 | Mean | 146.50 | 183.83 | 197.00 | 25.58 | 34.66 |
SD | 7.99 | 7.39 | 6.03 | 2.58 | 4.96 | |
n | 6 | 6 | 6 | 6 | 6 | |
G2/ 2000 | Mean | 153.17 | 203.33 | 213.33 | 32.48 | 39.03 |
SD | 6.08 | 25.94 | 26.32 | 13.31 | 13.51 | |
n | 6 | 6 | 6 | 6 | 6 |
Keys:SD = Standard Deviation, n = Number of Animals
Table 3: Individual Animal Clinical Signs and Symptoms
Sex:Female
Animal No. | Group/ Dose (mg/kg body weight) | Hours (Day 0) | ||||
1/2 | 1 | 2 | 3 | 4 | ||
1 | G1/ 300 | 1 | 1 | 1 | 1 | 1 |
2 | 1 | 1 | 1 | 1 | 1 | |
3 | 1 | 1 | 1 | 1 | 1 | |
4 | 1 | 1 | 1 | 1 | 1 | |
5 | 1 | 1 | 1 | 1 | 1 | |
6 | 1 | 1 | 1 | 1 | 1 | |
7 | G2/ 2000 | 1 | 1 | 1 | 1 | 1 |
8 | 1 | 1 | 1 | 1 | 1 | |
9 | 1 | 1 | 1 | 1 | 1 | |
10 | 1 | 1 | 1 | 1 | 1 | |
11 | 1 | 1 | 1 | 1 | 1 | |
12 | 1 | 1 | 1 | 1 | 1 |
Key: 1 = Normal
Table 4: Individual Animal Mortality Record
Sex:Female
Animal No. | Group/ Dose (mg/kg body weight) | Day of Observation (Day 0 to 14) | |
Morning Observation | Evening Observation | ||
1 | G1/ 300 | No mortality and morbidity | No mortality and morbidity |
2 | No mortality and morbidity | No mortality and morbidity | |
3 | No mortality and morbidity | No mortality and morbidity | |
4 | No mortality and morbidity | No mortality and morbidity | |
5 | No mortality and morbidity | No mortality and morbidity | |
6 | No mortality and morbidity | No mortality and morbidity | |
7 | G2/ 2000 | No mortality and morbidity | No mortality and morbidity |
8 | No mortality and morbidity | No mortality and morbidity | |
9 | No mortality and morbidity | No mortality and morbidity | |
10 | No mortality and morbidity | No mortality and morbidity | |
11 | No mortality and morbidity | No mortality and morbidity | |
12 | No mortality and morbidity | No mortality and morbidity |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 (Cut-off value) of Reaction mass of Cardanol diene and Cardanol monoene and Cardanol triene (CAS No. – 37330-39-5) was 5000 mg/kg body weight.
- Executive summary:
Acute Oral Toxicity was studied of Reaction mass of Cardanol diene and Cardanol monoene and Cardanol triene (CAS No. – 37330-39-5) in Rats.
Three rats of the first group G1 were dosed with starting dose of 300 mg/kg body weight and the animals did not show any mortality. So another three animals of the same group G1 were dosed with 300 mg/kg body weight and no mortality was observed. Next, three animals of group G2 were dosed with 2000 mg/kg body weight and no mortality was observed.
Under the conditions of this; and based on the examinations performed, acute oral toxicity study of Reaction mass of Cardanol diene and Cardanol monoene and Cardanol triene (CAS No. – 37330-39-5)in female rats is as given below:
The acute oral LD50(Cut-off value) of Cardanol (CAS No. – 37330-39-5) was 5000 mg/kgbody weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.